Latest Hikma News & Updates

See the latest news and media coverage for Hikma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hikma

Global pharmaceutical company

hikma.com

Headquarters: London, United Kingdom
Founded year: 1978
Company type: Public company
Number of employees: 5,000–15,000

Last updated Today

Latest news about Hikma

In short: Hikma secured a unanimous U.S. Supreme Court win in a major patent case while reporting revenue growth and expanding its manufacturing operations.

Company announcements

June 4 Hikma

Hikma publishes 2025 Sustainability Report reaffirming access to medicine

The report covers 222 million patients treated, 84 new products, and 18% emissions reduction.

June 4 Hikma

Hikma wins unanimous Supreme Court decision in patent case

The court effectively ended Amarin's patent infringement lawsuit against Hikma, allowing continued sale of generic icosapent ethyl.

June 2 Hikma

Hikma expands manufacturing operations in Ohio

The expansion will create 350 new jobs and is part of $1B in US investments.

May 7 Hikma

Hikma's CEO outlines company's purpose

Said Darwazah emphasizes reliable, affordable medicines across Injectables, Branded, and Hikma Rx segments, highlighting growth, investments, and MENA leadership. Targets $5B revenue by 2030.

Media coverage

June 15 HealthCare Middle East & Africa

Hikma Pharmaceuticals announces US$267M manufacturing expansion across Ohio | HealthCare Middle East & Africa - No.1 Health & Pharma Manufacturing Industry Publication

The company has invested nearly US$5 billion in the United States over the past 15 years, expanding its manufacturing, research, development, and distribution infrastructure.

June 12 JD Supra

Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc.

In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice Jackson, the Supreme...

June 11 Bloomberg Law

High Court 'Skinny Label' Ruling Is No Generic Drug Free-for-All

Opinion: Generic drug manufacturers should view the Supreme Court's ruling in Hikma v. Amarin as a limited safe harbor against liability when they comply with...

June 5 JD Supra

No "Skinny Dipping" into Liability: SCOTUS Delivers Win for Generic Drugs

The manufacture and distribution of generic pharmaceutical drugs is a polarizing topic in the political and legal world. The manufacturing...

Never miss news about Hikma

Track Hikma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Hikma competitors & trending companies

Browse news for competitors to Hikma and other trending companies.